High Vista Strategies LLC Adverum Biotechnologies, Inc. Transaction History

High Vista Strategies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.36 - $10.56 $218,084 - $685,407	-64,906 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.26 - $14.36 $96,128 - $149,071	10,381 Added 19.04%	64,906 $640,000
Q4 2020 Feb 16, 2021	BUY	$9.84 - $14.26 $184,273 - $267,047	18,727 Added 52.31%	54,525 $591,000
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $98,880 - $207,744	9,600 Added 36.64%	35,798 $369,000
Q2 2020 Aug 14, 2020	BUY	$8.53 - $25.64 $223,468 - $671,716	26,198 New	26,198 $547,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.